Adjunctive use of celecoxib with anti-tuberculosis drugs: evaluation in a whole-blood bactericidal activity model
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adjunctive use of celecoxib with anti-tuberculosis drugs: evaluation in a whole-blood bactericidal activity model
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-04
DOI
10.1038/s41598-018-31590-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activity of faropenem with and without rifampicin against Mycobacterium tuberculosis: evaluation in a whole-blood bactericidal activity trial
- (2017) Meera Gurumurthy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection
- (2016) Kristian Tonby et al. BMC INFECTIOUS DISEASES
- Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers
- (2016) Robert S Wallis et al. LANCET INFECTIOUS DISEASES
- Adjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate Vaccination
- (2016) Lakshmi Jayashankar et al. Frontiers in Immunology
- Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial
- (2016) Daniel F. Hoft et al. EBioMedicine
- Selective Inactivity of Pyrazinamide against Tuberculosis in C3HeB/FeJ Mice Is Best Explained by Neutral pH of Caseum
- (2015) Jean-Philippe Lanoix et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population pharmacokinetics of rifampicin and 25-deacetyl-rifampicin in healthy Asian adults
- (2015) Kok-Yong Seng et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Development and validation of liquid chromatography tandem mass spectrometry method for simultaneous quantification of first line tuberculosis drugs and metabolites in human plasma and its application in clinical study
- (2015) Kim H. Hee et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Verapamil, and Its Metabolite Norverapamil, Inhibit Macrophage-induced, Bacterial Efflux Pump-mediated Tolerance to Multiple Anti-tubercular Drugs
- (2014) Kristin N. Adams et al. JOURNAL OF INFECTIOUS DISEASES
- Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
- (2014) Katrin D. Mayer-Barber et al. NATURE
- Mycobactericidal Activity of Sutezolid (PNU-100480) in Sputum (EBA) and Blood (WBA) of Patients with Pulmonary Tuberculosis
- (2014) Robert S. Wallis et al. PLoS One
- Ibuprofen Therapy Resulted in Significantly Decreased Tissue Bacillary Loads and Increased Survival in a New Murine Experimental Model of Active Tuberculosis
- (2013) Cristina Vilaplana et al. JOURNAL OF INFECTIOUS DISEASES
- Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistantMycobacterium tuberculosisthrough Efflux
- (2011) Gail E. Louw et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Prostaglandins and Inflammation
- (2011) Emanuela Ricciotti et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Control of experimental pulmonary tuberculosis depends more on immunostimulatory leukotrienes than on the absence of immunosuppressive prostaglandins
- (2011) C. Peres-Buzalaf et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Inhibition of Bacterial Multidrug Resistance by Celecoxib, a Cyclooxygenase-2 Inhibitor
- (2010) Arunasree M. Kalle et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biomarker-Assisted Dose Selection for Safety and Efficacy in Early Development of PNU-100480 for Tuberculosis
- (2010) Robert S. Wallis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line
- (2009) Karnati R. Roy et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Comparative Inhibitory Activity of Etoricoxib, Celecoxib, and Diclofenac on COX-2 Versus COX-1 in Healthy Subjects
- (2008) Jules I. Schwartz et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Role of Dose Potency in the Prediction of Risk of Myocardial Infarction Associated With Nonsteroidal Anti-Inflammatory Drugs in the General Population
- (2008) Luis Alberto García Rodríguez et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started